Context Therapeutics Inc. (CNTX)
NASDAQ: CNTX · Real-Time Price · USD
1.050
+0.020 (1.94%)
Dec 5, 2025, 4:00 PM EST - Market closed
Context Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 112 | 94 | 18 | 10 | 42 | - | |
| Market Cap Growth | -15.72% | 422.07% | 73.39% | -75.50% | - | - | |
| Enterprise Value | 35 | 10 | -4 | -29 | 63 | - | |
| Last Close Price | 1.05 | 1.05 | 1.13 | 0.65 | 2.66 | - | |
| PB Ratio | 1.32 | 0.99 | 1.52 | 0.30 | 0.88 | - | |
| P/TBV Ratio | 1.53 | 0.99 | 1.52 | 0.30 | 0.88 | - | |
| Debt / Equity Ratio | 0.00 | 0.00 | - | 0.00 | - | -0.65 | |
| Quick Ratio | 12.75 | 34.36 | 3.45 | 11.07 | 16.36 | 0.03 | |
| Current Ratio | 13.10 | 35.62 | 3.83 | 11.80 | 16.90 | 0.03 | |
| Return on Equity (ROE) | -33.68% | -49.89% | -102.79% | -35.74% | -53.50% | - | |
| Return on Assets (ROA) | -22.81% | -32.76% | -58.01% | -20.84% | -17.96% | -433.97% | |
| Return on Capital (ROIC) | -23.99% | -34.84% | -67.13% | -22.39% | -20.64% | - | |
| Return on Capital Employed (ROCE) | -41.30% | -31.40% | -211.20% | -42.80% | -15.40% | 28.30% | |
| Earnings Yield | -23.63% | -28.37% | -132.83% | -142.58% | -24.63% | - | |
| FCF Yield | -20.00% | -15.46% | -116.66% | -130.57% | -20.72% | - | |
| Buyback Yield / Dilution | -119.13% | -265.88% | - | -463.44% | -37.90% | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.